Abbott to spin off nutrition unit into independent public company

✦ Meridian Analysis

Abbott has announced that it intends to separate its nutrition division, which generates $8.5 billion of annual sales, into an independent publicly listed company. The plan is still at the rumour stage; no definitive mandate, pricing or regulatory filing has been disclosed. In a typical spin‑off, the parent retains a minority stake while distributing the remainder of the shares to existing shareholders, creating a new issuer that can raise capital on its own balance sheet. Potential investors, including institutional and retail shareholders, would acquire equity in the newly listed entity, while any debt financing required for the carve‑out would be arranged separately, though details on lenders or financing terms have not been released. Key points to monitor include the valuation range that Abbott will target for the spin‑off, the composition of the advisory team, and the timeline for shareholder approval and listing. Neither the price nor the multiple applied to the nutrition unit has been disclosed, nor have any financing arrangements or regulatory clearances been announced.

The Meridian Weekly